In a recent study by Backman et al., three out of 14 patients with MEN1 syndrome, but no pathogenic MEN1 variant found on clinical genetic testing, actually did carry a pathogenic variant when re-analysed [46]. This evidence concerns the gene MEN1 and multiple endocrine neoplasia type 1.